Patents Assigned to Lacerta Technologies, Inc.
  • Patent number: 10111906
    Abstract: The invention provides for a method of preparing an isolated serum fraction of platelet rich fibrin (PRF), comprising the steps of a. providing platelet rich plasma (PRP) without the addition of an anticoagulant; b. clotting the PRP to obtain a coagel of PRF; and c. separating the coagel to isolate the serum fraction which comprises an activated platelet releasate; and further provides for the isolated serum fraction obtained by such method, and its medical use.
    Type: Grant
    Filed: October 3, 2016
    Date of Patent: October 30, 2018
    Assignee: Lacerta Technologies Inc.
    Inventors: Zsombor Lacza, Gabriella Vácz
  • Patent number: 9770530
    Abstract: The present invention relates to a tissue substitute material for implantation, comprising (a) a substrate to be implanted covered with (b) a controlled release coating containing (c) at least one biologically substance that decreases bacterial growth, wherein the (b) controlled release coating is a bioavailable, biocompatible polymer material and wherein the (c) at least one biologically active substance that decreases bacterial growth. The present invention also relates to a method to prepare the tissue substitute material, as wells the uses thereof.
    Type: Grant
    Filed: February 11, 2014
    Date of Patent: September 26, 2017
    Assignee: Lacerta Technologies Inc.
    Inventors: Zsombor Lacza, István Hornyák, Pálma Kalugyer, Edit Madácsi
  • Patent number: 9480716
    Abstract: The invention provides for a method of preparing an isolated serum fraction of platelet rich fibrin (PRF), comprising the steps of a. providing platelet rich plasma (PRP) without the addition of an anticoagulant; b. clotting the PRP to obtain a coagel of PRF; and c. separating the coagel to isolate the serum fraction which comprises an activated platelet releasate; and further provides for the isolated serum fraction obtained by such method, and its medical use.
    Type: Grant
    Filed: February 12, 2014
    Date of Patent: November 1, 2016
    Assignee: Lacerta Technologies Inc.
    Inventors: Zsombor Lacza, Gabriella Vácz
  • Patent number: 9381272
    Abstract: Methods for producing implantable bone compositions suitable for attaching stem cells thereto, characterized in that bone particles are contacted with an albumin comprising solution. Said bone particles can be mineralized and/or lyophilized bone particles of animal or human origin. Preferably the non-immunogenic albumin comprising solution is lyophilized onto said bone particles. The invention further concerns bone compositions suitable for using in graft implantation obtainable by said methods.
    Type: Grant
    Filed: October 7, 2013
    Date of Patent: July 5, 2016
    Assignee: Lacerta Technologies Inc.
    Inventors: Zsombor Lacza, Miklós Weszl
  • Publication number: 20150367032
    Abstract: The present invention relates to a tissue substitute material for implantation, comprising (a) a substrate to be implanted covered with (b) a controlled release coating containing (c) at least one biologically substance that decreases bacterial growth, wherein the (b) controlled release coating is a bioavailable, biocompatible polymer material and wherein the (c) at least one biologically active substance that decreases bacterial growth. The present invention also relates to a method to prepare the tissue substitute material, as wells the uses thereof.
    Type: Application
    Filed: February 11, 2014
    Publication date: December 24, 2015
    Applicant: LACERTA TECHNOLOGIES INC.
    Inventors: Zsombor LACZA, István HORNYÁK, Pálma KALUGYER, Edit MADÁCSI
  • Publication number: 20140227241
    Abstract: The invention provides for a method of preparing an isolated serum fraction of platelet rich fibrin (PRF), comprising the steps of a. providing platelet rich plasma (PRP) without the addition of an anticoagulant; b. clotting the PRP to obtain a coagel of PRF; and c. separating the coagel to isolate the serum fraction which comprises an activated platelet releasate; and further provides for the isolated serum fraction obtained by such method, and its medical use.
    Type: Application
    Filed: February 12, 2014
    Publication date: August 14, 2014
    Applicant: LACERTA TECHNOLOGIES INC.
    Inventors: Zsombor LACZA, GABRIELLA VACZ
  • Publication number: 20140044792
    Abstract: Methods for producing implantable bone compositions suitable for attaching stem cells thereto, characterized in that bone particles are contacted with an albumin comprising solution. Said bone particles can be mineralized and/or lyophilized bone particles of animal or human origin. Preferably the non-immunogenic albumin comprising solution is lyophilized onto said bone particles. The invention further concerns bone compositions suitable for usin in graft implantation obtainable by said methods.
    Type: Application
    Filed: October 7, 2013
    Publication date: February 13, 2014
    Applicant: LACERTA TECHNOLOGIES, INC.
    Inventors: Zsombor Lacza, Miklós Weszl
  • Publication number: 20130343967
    Abstract: The device enables to put the patients own bone marrow derived stem cells on a lyophilized bone allograft covered by human albumin, after a short separation by centrifugation. The cell concentrator comprises a closed housing (1, 2) for receiving a syringe (7) for holding tissue aspirates and a container (12) below said syringe (7) for receiving the concentrate received by centrifugation; means for clamping the syringe within said housing (1, 2); means for releasable locking the plunger (6) of the syringe (7) and means for pushing the plunger (6) of the syringe (7) along a predetermined length, to introduce at least a part of the concentrate into said container (12). The built-in pushbutton mechanism designed to spray the proper amount of stem cell rich fluid to the surface of the bone graft.
    Type: Application
    Filed: January 6, 2011
    Publication date: December 26, 2013
    Applicant: LACERTA TECHNOLOGIES INC.
    Inventors: Viktor Izápy, Miklós Weszl, Zsombor Lacza
  • Publication number: 20130344579
    Abstract: The imaging chamber according to the invention comprises a housing with a lower part and an upper part, wherein said lower part is a dish (1) and said upper part is a lid (2) provided with a skirt (9) surrounding the upper rim (10) of the dish (1), the bottom of the dish (1) is provided with a cover slip (12) to be used in confocal microscopy and at least a part of the lid (2) is transparent wherein the lid (2) is provided with a breathing silicon insert (5). The silicon insert (5) comprises a circular ring part fixed to the inner surface of the lid (2) and a skirt (14) parallel with the upper rim (10) of the dish (1) and supported by the skirt (9) of the lid (2) and provided with an annular groove (15) tight fitted on the upper rim (10) of the dish (1); and the lid (2) is provided with openings (4) to allow breathing of the housing.
    Type: Application
    Filed: January 11, 2011
    Publication date: December 26, 2013
    Applicant: LACERTA TECHNOLOGIES INC.
    Inventors: Viktor Izápy, Õdön Wagner, Zsombor Lacza, Miklós Weszl
  • Patent number: 8551170
    Abstract: Disclosed are methods for producing implantable bone compositions suitable for attaching stem cells thereto, characterized in that bone particles are contacted with an albumin comprising solution. Said bone particles can be mineralized and/or lyophilized bone particles of animal or human origin. Preferably the non-immunogenic albumin comprising solution is lyophilized onto said bone particles. The invention further concerns bone compositions suitable for use in graft implantation obtainable by said methods.
    Type: Grant
    Filed: February 26, 2009
    Date of Patent: October 8, 2013
    Assignee: Lacerta Technologies, Inc.
    Inventors: Zsombor Lacza, Miklós Weszl